Chimpanzee models for human disease and immunobiology

Area of Science:

• Comparative genomics
• Immunology
• Biochemistry

Background:

• Humans and chimpanzees share over 98% genomic homology but exhibit distinct responses to HIV-1 and HBV, and differing cancer incidences.
• While major histocompatibility complex (MHC) alleles show little overlap, epitope binding repertoires for HIV-1 and HBV are similar, suggesting non-T cell involvement in viral handling.
• Differences in host response to viral and malignant cells may stem from cell-cell interactions mediated by sialic acid-binding proteins.

Purpose of the Study:

• To explore the biochemical differences between humans and chimpanzees that may underlie variations in immune responses and disease susceptibility.
• To investigate the role of sialic acid structures, specifically N-glycolyl neuraminic acid (Neu5Gc), in mediating cellular interactions and immune kinetics.

Main Methods:

• Comparative analysis of genomic sequences and immune response pathways between humans and chimpanzees.
• Focus on cell-cell interactions involving sialic acid-binding proteins (lectins).
• Examination of the biochemical impact of the absence of N-glycolyl neuraminic acid (Neu5Gc) in humans.

Main Results:

• Humans uniquely lack N-glycolyl neuraminic acid (Neu5Gc) due to a gene mutation in its synthetic pathway.
• The absence of Neu5Gc in humans is the only known major biochemical difference compared to chimpanzees.
• This biochemical difference may alter the kinetics of cellular responses dependent on sialic acid-binding proteins.

Conclusions:

• The lack of Neu5Gc in humans is a critical biochemical divergence from chimpanzees.
• This difference may significantly influence immune responses to viruses like HIV-1 and HBV, as well as host defense against epithelial malignancies.
• Further research into sialic acid-mediated cell interactions is warranted to fully understand human-specific disease susceptibilities.